Creative Biolabs’ DASS Has Unprecedentedly Accomplished 100% Accurate Distinction Between Leucine and Isoleucine
Creative Biolabs
13/08/2019With more than 25 years of experience as a CRO company, Creative Biolabs has recently made a tremendous breakthrough in the field of de novo monoclonal antibody sequencing with the Database Assisted Shotgun Sequencing (DASS) technology. The DASS is advanced from the Next Generation Sequencing (NGS) platform, which was used to sequence the variable regions, variable plus leader regions, as well as the full-length heavy and light-chain antibodies of all species, isotypes,...